About Vera Therapeutics
Vera Therapeutics is a company based in San Francisco (United States) founded in 2016 by Marshall Fordyce.. Vera Therapeutics has raised $196.58 million across 5 funding rounds from investors including Fidelity Investments, ARE and Kleiner Perkins. The company has 112 employees as of December 31, 2024. Vera Therapeutics offers products and services including Atacicept. Vera Therapeutics operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter San Francisco, United States
- Employees 112 as on 31 Dec, 2024
- Founders Marshall Fordyce
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vera Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-152.15 M-58.5as on Dec 31, 2024
-
EBITDA
$-165 M-58.85as on Dec 31, 2024
-
Total Equity Funding
$196.58 M (USD)
in 5 rounds
-
Latest Funding Round
$80 M (USD), Series C
Jan 19, 2021
-
Investors
Fidelity Investments
& 8 more
-
Employee Count
112
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vera Therapeutics
Vera Therapeutics is a publicly listed company on the NASDAQ with ticker symbol VERA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vera Therapeutics
Vera Therapeutics offers a comprehensive portfolio of products and services, including Atacicept. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for treating IgA Nephropathy in clinical trials
Unlock access to complete
Unlock access to complete
Leadership Team
33 people
Software Development Team
6 people
Operations Team
5 people
Finance and Accounting
4 people
Product Management Team
4 people
Sales and Marketing
3 people
Program Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of Vera Therapeutics
Vera Therapeutics has successfully raised a total of $196.58M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $80 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $80.0M
-
First Round
First Round
(19 Apr 2016)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series C - Vera Therapeutics | Valuation |
investors |
|
| Oct, 2020 | Amount | Series C - Vera Therapeutics | Valuation | Abingworth | |
| Sep, 2019 | Amount | Series B - Vera Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vera Therapeutics
Vera Therapeutics has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, ARE and Kleiner Perkins. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location | |
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vera Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vera Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vera Therapeutics Comparisons
Competitors of Vera Therapeutics
Vera Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vera Therapeutics
Frequently Asked Questions about Vera Therapeutics
When was Vera Therapeutics founded?
Vera Therapeutics was founded in 2016.
Where is Vera Therapeutics located?
Vera Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Vera Therapeutics?
Marshall Fordyce is the current CEO of Vera Therapeutics. They have also founded this company.
Is Vera Therapeutics a funded company?
Vera Therapeutics is a funded company, having raised a total of $196.58M across 5 funding rounds to date. The company's 1st funding round was a Series B of $34M, raised on Apr 19, 2016.
How many employees does Vera Therapeutics have?
As of Dec 31, 2024, the latest employee count at Vera Therapeutics is 112.
What does Vera Therapeutics do?
Developer of therapeutic solutions for the treatment of immunological and inflammatory diseases. The company has an atacicept novel biologic drug that is a human recombinant fusion protein that helps in treating IgA nephropathy which is a rare autoimmune disease. It contains a soluble TACI receptor that binds to the cytokines BLyS and APRIL to promote B-cell survival and autoantibody production for the treatment of autoimmune diseases.
Who are the top competitors of Vera Therapeutics?
Vera Therapeutics's top competitors include ADMA Biologics, BioNTech and Generate Biomedicines.
What products or services does Vera Therapeutics offer?
Vera Therapeutics offers Atacicept.
Is Vera Therapeutics publicly traded?
Yes, Vera Therapeutics is publicly traded on NASDAQ under the ticker symbol VERA.
Who are Vera Therapeutics's investors?
Vera Therapeutics has 9 investors. Key investors include Fidelity Investments, ARE, Kleiner Perkins, HHS, and Abingworth.
What is Vera Therapeutics's ticker symbol?
The ticker symbol of Vera Therapeutics is VERA on NASDAQ.